Nanocarriers to solid tumors: Considerations on tumor penetration and exposure of tumor cells to therapeutic agents

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1306-1316

  Bhagat, Manali ^a   Halligan, Susan ^a   Sofou, Stavroula ^b  

^a POLYTECHNIC UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Liposomes; Micelles; Targeted delivery; Triggered release; Tumor penetration

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; GOLD NANOPARTICLE; LIPOSOME; MALEIC ACID; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; NANOCARRIER; PACLITAXEL;

DRUG EXPOSURE; DRUG PENETRATION; HUMAN; MAGNETIC FIELD; MICELLE; NONHUMAN; PH; PHOTODYNAMIC THERAPY; REVIEW; SOLID TUMOR; TUMOR CELL;

EID: 84861160747     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624256     Document Type: Review

References (100)

1. Jain, K. Transport of molecules, particles, and cells in solid tumors. Ann. Rev. Biomed. Eng., 1999, 1, 241-263.
2. Minchinton, A.; Tannock, I. Drug penetration in solid tumours. Nat. Rev. Cancer, 2006, 6, 583-92.
3. Zaidi, H.; Sgouros, G. Therapeutic Applications of Monte Carlo Calculations in Nuclear Medicine. IoP: Bristol, 2003.
4. Thurber, G. M.; Schmidt, M. M.; Wittrup, K. D. Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance. Adv. Drug Deliv. Rev., 2008, 60(12), 1421-1434.
5. Thurber, G. M.; Zajic, S. C.; Wittrup, K. D. Theoretic criteria for antibody penetration into solid tumors and micrometastases. J. Nucl. Med., 2007, 48(6), 995-999.
6. Lee, H.; Fonge, H.; Hoang, B.; Reilly, R. M.; Allen, C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol. Pharm., 2011, 7(4), 1195-1208.
7. Sofou, S. Surface-active liposomes for targeted cancer therapy. Nanomed., 2007, 2, 711-724
8. Sofou, S.; Sgouros, G. Antibody-targeted liposomes in cancer therapy and imaging. Expert Opin. Drug Deliv., 2008, 5(2), 189-204.
9. Jain, R. K.; Munn, L. L.; Fukumura, D. Dissecting tumor pathophysiology using intravital microscopy. Nat. Rev. Cancer, 2002, 2, 266-276.
10. Hobbs, S. K.; Monsky, W. L.; Yuan, F.; Roberts, W. G.; Griffith, L.; Torchilin, V. P.; Jain, R. K. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA, 1998, 95, 4607-4612.
11. Noguchi, Y.; Wu, J.; Duncan, R.; Strohalm, J.; Ulbrich, K.; Akaike, T.; Maeda, H. Early phase tumor accumulation of macromolecules: A great difference between the tumor vs. normal tissue in their clearance rate. Jpn J. Cancer Res., 1998, 89, 307-314.
12. Young, J.; Lumsden, C.; Stalker, A. The significance of the tissue pressure of normal testicular and of neoplastic (Brown-Pearce carcinoma) tissue in the rabbit. J. Pathol. Bacteriol., 1950, 62, 313-33.
13. Jain, R. Transport of molecules in the tumor interstitium: A Review. Canser Res., 1987, 47, 3039-3051.
14. Heldin, C.; Rubin, K.; Pietras, K.; Ostman, A. High intersial fluid pressure-an obstacle in cancer therapy. Nat. Rev. Can., 2004, 4, 806-813.
15. Netti, P.; Berk, D.; Swartz, M.; Grodzinsky, A.; Jain, R. Role of extracellular matrix assembly in interstitial transport in solid tumors. Canser Res., 2000, 60, 2497-2503.
16. Swabb, E.; Wei, J.; Gullino, P. Diffusion and convection in normal and neoplastic tissues. Can Res., 1974, 34, 2814-2822.
17. Helmlinger, G.; Yuan, F.; Dellian, M.; Jain, R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med., 1997, 3, 177-182.
18. Vaupel, P.; Kallinowski, F.; Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res., 1989, 49(23), 6449-6465.
19. Wike-Hooley, J.; van den Berg, A.; van der Zee, J.; Reinhold, H. Human tumour pH and its variation. Eur. J. Cancer Clin. Oncol., 1985, 21, 785-791.
20. Warburg, O.; Posener, K.; Negelein, E. Uber den Stoffwechsel der Carcinomzelle. Biochem. Z., 1924, 152, 309-344.
21. Gerwec, L. Causes and consequences of tumour acidity and implications for treatment. Semin. Rad. Oncol., 1998, 8, 176-182.
22. Stubbs, M.; McSheehy, P.; Griffiths, J.; Bashford, C. Causes and consequences of tumour acidity and implications for treatment. Mol. Med. Today, 2000, 6, 15-19.
23. Tannock, I.; Rotin, D. Human tumour pH and its variation. Cancer Res., 1989, 49, 4373-4384.
24. Casciari, J.; Sotirchos, S.; Sutherland, R. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J. Cell. Phys., 1992, 151, 386-394.
25. Hirst, D.; Denekamp, J. Tumour cell proliferation in relation to the vasculature. Cell Tiss. Kinetics, 1979, 12, 31-42.
26. Batchelder, R.; Wilson, W.; Hay, M.; Denny, W. Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1. Br. J. Cancer. Suppl., 1996, 27, 52-56.
27. Shannon, A. M.; Bouchier-Hayes, D. J.; Condron, C. M.; Toomey, D. Tumour hypoxia, chemotherapeutic resistance and hypoxiarelated therapies. Cancer Treat Rev., 2003, 29, 297-307.
28. Teicher, B. A. Hypoxia and drug resistance. Cancer Metastasis Rev., 1994, 13, 139-168.
29. Brown, J.; Wilson, W. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer, 2004, 4, 437-447.
30. Liu, S.; Minton, N.; Giaccia, A.; Brown, J. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Gene Ther., 2002, 9, 291-296.
31. Kasinskas, R.; Forbes, N. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res., 2007, 67, 3201-309.
32. Gottesman, M.; Fojo, T.; Bates, S. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, 2002, 2, 48-58.
33. Stavrovskaya, A. Cellular mechanisms of multidrug resistance of tumor cells. Biochem. (Moscow), 2000, 65, 95-106.
34. Ganta, S.; Devalapally, H.; Shahiwala, A.; Amij, I. M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Contr Rel., 2008, 126, 187-204.
35. Davies Cde, L.; Lundstrøm, L.; Frengen, J.; Eikenes, L.; Bruland, S.; Kaalhus, O.; Hjelstuen, M.; Brekken, C. Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts. Cancer Res., 2004, 64, 547-553.
36. Eikenes, L.; Tari, M.; Tufto, I.; Bruland, O.; de Lange Davies, C. Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts. Br. J. Cancer, 2005, 11, 81-88.
37. Kong, G.; Anyarambhatla, G.; Petros, W. P.; Braun, R. D.; Colvin, O. M.; Needham, D.; Dewhirst, M. W. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res., 2000, 60(24), 6950-6957.
38. Kalofonos, H.; Rowlinson, G.; Epenetos, A. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation. Cancer Res., 1990, 50, 159-163.
39. Frenkel, V., Ultrasound mediated delivery of drugs and genes to solid tumors. Drug Deliv. Rev., 2008, 60, 1193-1208.
40. Drummond, D. D.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev., 1999, 51, 691-743.
41. Lee, H.; Fonge, H.; Hoang, B.; Reilly, R. M.; Allen, C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol. Pharm., 2011, 7(4),1195-1208.
42. Torchilin, V. P. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv. Drug Deliv. Rev., 2008, 60(4-5), 548-558.
43. Sawant, R. M.; Hurley, J. P.; Salmaso, S.; Kale, A.; Tolcheva, E.; Levchenko, T. S.; Torchilin, V. P. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconj. Chem., 2006, 17(4), 943-949.
44. Kale, A. A.; Torchilin, V. P. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes. J. Drug Targeting, 2007, 15(7-8), 538-545.
45. Karve, S.; Bandekar, A.; Ali, M. R.; Sofou, S. The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity. Biomat, 2010, 31, 4409-4416.
46. Bajagur Kempegowda, G.; Karve, S.; Bandekar, A.; Adhikari, A.; Khaimchayev, T.; Sofou, S. pH-dependent formation of lipid heterogeneities controls surface topography and binding reactivity in functionalized bilayers. Langmuir, 2009, 25, 8144-8151.
47. Eikenes, L.; Tari, M.; Tufto, I.; Bruland, O. S.; de Lange Davies, C. Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (CaelyxTM) in human osteosarcoma xenografts. Br. J. Cancer, 2005, 93, 81-88.
48. Smith, K. J.; Skelton, H. G.; Turiansky, G.; Wagner, K. F. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. J. Am. Acad. Dermatol., 1997, 36(2), 239-242.
49. Bruera, E.; Neumann, C. M.; Pituskin, E.; Calder, K.; Hanson, J. A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration. Ann. Oncol., 1999, 10(10), 1255-1258.
50. Menon, P.; Smith, K. J.; Crittenden, J.; Skelton, H. Adjuvant therapy with hyaluronidase prior to excision of dermatofibrosarcoma protuberans. Dermat. Surg., 1999, 25, 205-209.
51. Davies, C. L.; Lundstrom, L. M.; J., F.; Eikenes, L.; Bruland, O. S.; Kaalhus, O.; Hjelstuen, M. H. B.; Brekken, C. Radiation improves the distribution and uptake of liposomal Doxorubicin (Caelyx) in human osteosarcoma xenografts. Cancer Res., 2004, 64, 547-553.
52. Karve, S.; Bajagur Kempegowda, G.; Sofou, S. Heterogeneous domains and membrane permeability in phosphatidylcholinephosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch. Langmuir, 2008, 24, 5679-5688.
53. Karve, S.; Alaouie, A.; Zhou, Y.; Rotolo, J.; Sofou, S. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy. Biomat, 2009, 30, 6055-6064.
54. Kong, G.; Braun, R.; Dewhirst, M. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res., 2001, 61, 3027-3032.
55. Papahadjopoulos, D.; Jacobson, K.; Nir, S.; Isac, I. Phase transitions in phospholipid vesicles Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. BBA-Biomembranes, 1973, 311(3), 330-348.
56. Weinstein, J.; Magin, R.; Yatvin, M.; Zaharko, D. Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science, 1979, 204, 188-191.
57. Needham, D.; Dewhirst, M. W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv. Drug Deliv. Rev., 2001, 53(3), 285-305.
58. Ponce, A.; Vujaskovic, Z.; Yuan, F.; Needham, D.; Dewhirst, M. Hyperthermia mediated liposomal drug delivery. Int. J. Hyperthermia, 2006, 22, 205-13.
59. Tai, L. A.; Tsai, P. J.; Wang, Y. C.; Wang, Y. J.; Lo, L. W.; Yang, C. S. Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release. Nanotechnol., 2009, 20, 135101.
60. Pradhan, P.; Giri, J.; Rieken, F.; Koch, C.; Mykhaylyk, O.; Döblinger, M.; Banerjee, R.; Bahadur, D.; Plank, C. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J. Contr Rel., 2010, 142(1), 108-121.
61. Lin, H. Y.; Thomas, J. L. Factors affecting responsivity of unilamellar liposomes to 20 kHz ultrasound. Langmuir., 2004, 20, 6100-6106.
62. Schroeder, A. A.; Weisman, S.; Tzemach, D.; Najajreh, Y.; Gabizon, A.; Talmon, Y.; Kost, J.; Barenholz, Y. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir, 2007, 23, 4019-4025.
63. Berg, O. G.; Gelb, M. H.; Tsai, M.-D.; Jain, M. K. Interfacial Enzymology: The Secreted Phospholipase A2-Paradigm. Chem. Rev., 2001, 101(9), 2613-2654.
64. Rillema, J. A.; Osmialowski, E. C.; Linebaugh, B. E. Phospholipase A2 activity in 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors of rats. BBA-Lipids and Lipid Metabolism, 1980, 617(1), 150-155.
65. Mouritsen, O.G.; Andresen, T.L.; Halperin, A.; Jansen, P.L.; Jacobsen, A. F.; Jensen, U. B.; Weiss, M. Activation of interfacial enzymes at membrane surfaces. J. Phys. Cond. Mat., 2006, 18, S1293.
66. Andresen, T. L.; Jensen, S. S.; Kaasgaard, T.; Jørgensen, K. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2. Curr. Drug Deliv., 2005, 2, 353-362.
67. Huang, S.-L.; MacDonald, R.C. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release BBA-Biomembranes, 2004, 1665, 134-141.
68. Guo, J.; Xu, N.; Li, Z. M.; Zhang, S. L.; Wu, J.; Kim, D. H.; Marma, M. S.; Meng, Q. L.; Cao, H. Y.; Li, X. X.; Shi, S. D.; Yu, L.; Kalachikov, S.; Russo, J. J.; Turro, N. J.; Ju, J. Y. Four-color DNA sequencing with 3'-O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides. Proc. Natl. Acad. Sci. USA, 2008, 105, 9145-9150.
69. Zhu, L.; Huo, Z.; Wang, L.; Tong, X.; Xiao, Y.; Ni, K. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes. Int. J. Pharm., 2009, 370, 136-143.
70. Paasonen, L.; Laaksonen, T.; Johans, C.; Yliperttula, M.; Kontturi, K.; Urtti, A. Gold nanoparticles enable selective light-induced contents release from liposomes. J. Contr Rel., 2007, 122, 86-93.
71. Sethuraman, V.; Bae, Y. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J. Contr Rel., 2007, 118, 216-24.
72. Lee, E.; Gao, Z.; Bae, Y. Recent progress in tumor pH targeting nanotechnology. J. Contr. Rel., 2008, 132, 164-70.
73. Oh, K.; Kim, D.; You, H.; Ahn, Y.; Lee, E. pH-sensitive properties of surface charge-switched multifunctional polymeric micelle. Int. J. Pharm., 2009, 376, 134-140.
74. Lee, E.; Shin, H.; Na, K.; Bae, Y. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J. Contr Rel., 2003, 90, 363-374.
75. Rapoport, N. Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int. J. Pharm., 2004, 277, 155-162.
76. Rapoport, N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Progr. Polymer. Sci., 2007, 32, 962-990.
77. Goodwin, A. P.; Mynar, J. L.; Ma, Y.; Fleming, G. R.; Frechet, J. M. J. Synthetic micelle sensitive to IR light via a two-photon process. J. Am. Chem. Soc., 2005, 127 9952-9953.
78. Nie, S.; Xing, Y.; Kim, G.; Simons, J. Nanotechnology applications in cancer. Ann. Rev. Biomed. Eng., 2007, 9, 257-88.
79. Eikenes, L.; Bruland, O. S.; Brekken, C.; Davies, C. L. Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res., 2004, 64, 4768-4773.
80. Goodman, T.; Olive, P.; Pun, S. Increased nano particle penetration in collagenase-treated multicellular spheroids. Int. J. Nanomed., 2007, 2, 265-274.
81. Mok, W.; Boucher, Y.; Jain, R. Matrix metalloproteinases-1 and-8 improve the distribution and efficacy of an oncolytic virus. Cancer Res., 2007, 67, 10664-10668.
82. Yahara, T.; Koga, T.; Yoshida, S.; Nakagawa, S.; Deguchi, H.; Shirouzu, K. Relationship between microvessel density and thermographic hot areas in breast cancer. Surg. Today, 2003, 33, 243-248.
83. Li, F.; Wua, H.; Zhang, H.; Li, F.; Gu, C.; Yang, Q. Novel super pH-sensitive nanoparticles responsive to tumor extracellular pH. Carbohyd. Polymers, 2008, 73, 390-400.
84. Li, F.; Wua, H.; Zhang, H.; Li, F.; Gu, C.; Yang, Q. Antitumor drug Paclitaxel-loaded pH-sensitive nanoparticles targeting tumor extracellular pH. Carbohyd. Polymers, 2009, 77, 773-778.
85. Li, Z.; Wang, J.; Chen, J.; Lei, W.; Wang, X.; Zhang, B. pHresponsive silica nanoparticles for controllable O2 generation. Nanotechnol, 2010, 21, 115102-115108.
86. Min, K. H.; Kim, J.-H.; Bae, S. M.; Shin, H.; Kim, M. S.; Park, S.; Lee, H.; Park, R.-W.; Kim, I.-S.; Kim, K.; Kwon, I. C.; Jeong, S. Y.; Lee, D. S. Tumoral acidic pH-responsive MPEG-poly([beta]-amino ester) polymeric micelles for cancer targeting therapy. 2010, J. Contr Rel., 144(2), 259-266.
87. Sawant, R. R.; Torchilin, V. P. Enhanced cytotoxicity of TATpbearing paclitaxel-loaded micelles in vitro and in vivo. Int. J. Pharm., 2009, 374(1-2), 114-118.
88. O'Neal, D. P.; Hirsch, L. R.; Halas, N. J.; Payne, J. D.; West, J. L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett., 2004, 209(2), 171-176.
89. Grantab, R.; Sivananthan, S.; Tannock, I. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res., 2006, 66, 1033-1039.
90. Kyle, A.; Huxham, L.; Chiam, A.; Sim, D.; Minchinton, A. Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. Cancer Res., 2004, 64, 6304-6309.
91. Fischbach, C.; Chen, R.; Matsumoto, T.; Schmelzle, T.; Brugge, J.; Polverini, P.; Mooney, D. Engineering tumors with 3D scaffolds. Nat. Methods, 2007, 4, 855-60.
92. Ong, S.; Zhao, Z.; Arooz, T.; Zhao, D.; Zhang, S.; Du, T.; Wasser, M.; van Noort, D.; Yu, H. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. Biomat, 2010, 31, 1180-1190.
93. Kunz-Schughart, L.; Freyer, J.; Hofstaedter, F.; Ebner, R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J. Biomol. Screen., 2004, 9, 273-85.
94. Fujimori, K.; Covell, D. G.; Fletcher, J. E.; Weinstein, J. N. Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors. Cancer Res., 1989, 49, 5656-5663.
95. Goodman, T. T.; Chen, J.; Matveev, K.; Pun, S. H. Spatio-temporal modeling of nanoparticle delivery to multicellular tumor spheroids. Biotech. Bioeng., 2008, 10, 388-399.
96. Graff, C. P.; Wittrup, K. D. Theoretical analysis of antibody targeting of tumor spheroids: Importance of dosage for penetration and affinity for retention. Cancer Res., 2003, 63, 1288-1296.
97. van Osdol, W.; Fujimori, K.; Weinstein, J. N. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier". Cancer Res., 1991, 51, 4776-4784.
98. Weinstein, J. N.; van Osdol, W. Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier". Cancer Res., 1992, 52, 2747-2751.
99. Lauffenburger, D. A.; Linderman, J. J. Receptors. Models for Binding, Trafficking, and Signaling. Oxford University press: 1995; p 376.
100. Saltzman, M. W. Engineering Principles for Drug Therapy. Oxford University Press: 2001; p 372.